Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,121 public trials 390 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Recruiting

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07071623

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • UW - KNH; Rachuonyo County Hospital ( Site 0006) Homabay County, Homa Bay County, Kenya
  • Partners in Health and Research Development (PHRD) ( Site 0002) Thika, Kiambu County, Kenya
  • KEMRI-CMR-RCTP ( Site 0003) Nairobi, Kisumu County, Kenya
  • Kargeno Research & Policy Hub ( Site 0007) Kisumu, Kenya
View all 30 locations
View Trial Details
Recruiting

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

NCT07044297

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 0006) Birmingham, Alabama, United States
  • USA Health University Hospitals ( Site 0020) Mobile, Alabama, United States
  • UCLA Center for Clinical AIDS Research and Education ( Site 0004) Los Angeles, California, United States
  • Bridge HIV - San Francisco Department of Public Health ( Site 0001) San Francisco, California, United States
View all 81 locations
View Trial Details
Recruiting

Genetic Basis of Immunodeficiency

NCT00055172

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +7 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

NCT04301076

Conditions
Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma, +21 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri, United States
  • Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States
View all 19 locations
View Trial Details

Related conditions